Share capital increase reserved for employees “Elis for All 2025” Saint-Cloud, 13 November 2025 The subscription period for the share capital increase reserved for Elis employees ended on 2 October 2025. 5.8% of employees in 20 countries chose to participate, either directly or via the Elis Group employee shareholding fund, in this operation, for a total subscription of nearly 15 million euros. Implemented by the Elis Supervisory Board on December 17, 2024 and by the Management Board on July 31, 2025, on th ...

At the EfTEN Real Estate Fund AS Annual General Meeting held on 8 April 2025, the shareholders authorised the Supervisory Board, for one year from the adoption of the resolution, to decide on increasing the fund’s share capital by carrying out public and/or private offerings, excluding the pre-emptive subscription rights of existing shareholders. Based on this resolution, the fund will conduct a directed share issue and raise a total of 1.6 million euros, mainly from Lithuania. The share price was set as th ...

Group 1 - The extraordinary general meeting of Havila Kystruten AS resolved to conduct a share consolidation in the ratio of 50:1 [1] - A share capital increase was approved to facilitate the share consolidation due to the current number of shares not being divisible by 50 [1] - Havila Holding AS, associated with primary insiders, subscribed for 41 shares in the share capital increase [2]

Core Points - The Board of Directors of Havila Kystruten AS has announced an extraordinary general meeting scheduled for November 7, 2025, at 10:00 CET [1] - The agenda includes the election of independent board members, a reverse share split in the ratio of 50:1, and a share capital increase to facilitate the share consolidation [2] - Shareholders with non-divisible shares will have their holdings rounded down, and fractional shares will be sold with proceeds donated to charity [3] - The meeting will be conducted digitally with electronic voting options available [4] Agenda Items - Election of Board members to ensure independence for potential refinancing [2] - Implementation of a reverse share split at a ratio of 50:1 [2] - Proposal for a share capital increase to support the share consolidation [2] - Authorization for the Board to set key dates related to the share consolidation and change of ISIN [2] Shareholder Information - Shareholders must hold a number of shares divisible by 50 to avoid rounding down [3] - Fractional shares will not be issued, and no compensation will be provided for rounding [3] - Proceeds from the sale of consolidated fractional shares will be donated to a charitable cause [3] Meeting Logistics - The extraordinary general meeting will be held as a digital meeting with electronic voting via Lumi [4] - Advance voting and proxy authorizations are permitted [4] - Relevant documents and meeting notice are available on the company's website [4]

Core Points - The Company announced the exercise of 19,470,726 Warrants, resulting in the subscription for the same number of new shares at an exercise price of NOK 1.00 each [1] - The Board of Directors has approved the allocation of new shares and resolved to increase the Company's share capital accordingly [2] - Following the registration of the share capital increase, the Company's total share capital will amount to NOK 429,142,639.50, divided into 858,285,279 shares with a nominal value of NOK 0.50 each [3] Company Overview - Ensurge Micropower is focused on developing ultrathin, flexible, reliable, and fundamentally safe solid-state lithium microbattery technology [3] - The Company operates with a team of forty specialists based in Silicon Valley, emphasizing innovation in microbattery technology suitable for various applications, including wearables and IoT devices [4] - Ensurge's manufacturing facility utilizes patented process technology and aims to scale production through partnerships with specialized industrial manufacturers [5] - The Company is listed on the Norwegian stock exchange and is supported by reputable financial investors, indicating a strong strategic investment and collaboration [6]

Core Points - Zealand Pharma A/S announced the total number of shares and voting rights as of September 30, 2025, following a share capital increase due to the exercise of employee warrants [1][2] - The total number of shares is 71,364,728, with a corresponding share capital of DKK 71,364,728 and the same number of voting rights [3] Company Overview - Zealand Pharma A/S is a biotechnology company focused on the discovery and development of innovative peptide-based medicines, with over 10 drug candidates in clinical development, including two that have reached the market and three in late-stage development [3] - The company was founded in 1998 and is headquartered in Copenhagen, Denmark, with a presence in the United States [4]

Group 1 - The company Kaldvik AS has resolved to settle a receivable of NOK 43,594,165 related to the acquisition of Mossi ehf. by issuing 1,579,498 new shares [1][2] - The new shares will be issued to Heimstø AS, which is associated with a primary insider of Kaldvik AS [2] - Following the share capital increase, the company's total share capital will amount to NOK 16,826,833.50, divided into 168,268,335 shares, each with a nominal value of NOK 0.10 [3] Group 2 - The company will register the new share capital increase with the Norwegian Register of Business Enterprises and will announce the completion of this registration [3] - This information is subject to the disclosure requirements of Regulation EU 596/2014 (MAR) and the Norwegian Securities Trading Act [4]

Group 1 - The Company, Grigeo Group AB, has announced that it received notifications of transactions conducted by persons discharging managerial responsibilities [1] - These transactions involve the acquisition of shares in the Company, completing the implementation of a resolution from the Annual General Meeting of Shareholders held on April 28, 2025, to increase the Company's share capital and approve revised Articles of Association [2] - Under this resolution, shares have been granted to employees of the Company and its subsidiaries free of charge through the issuance of new shares, which were fully paid from a reserve established for this purpose [3]

Core Points - The Board of EPSO-G has convened an Extraordinary General Meeting to discuss significant investment decisions [1] - EPSO-G plans to invest EUR 18,643,560 in its subsidiary UAB EPSO-G Invest by increasing its authorized capital and shares [2] - The meeting agenda includes the approval of the decision to increase shares in UAB EPSO-G Invest and the essential terms of the share subscription agreement [3] Company Structure - EPSO-G is a holding company with six direct subsidiaries: Amber Grid, Baltpool, Energy Cells, EPSO-G Invest, Litgrid, and Tetas [4] - EPSO-G and its subsidiaries also hold shares in GET Baltic, Baltic RCC OÜ, and TSO Holding AS [4] - The Ministry of Energy of the Republic of Lithuania exercises the rights and obligations of the sole shareholder of EPSO-G [4]

Core Viewpoint - Nordic Fibreboard AS is set to merge with Pärnu Riverside Development OÜ, with Nordic Fibreboard AS as the acquiring company, and the merger will not increase its share capital [1][4]. Group 1: Merger Details - The merger agreement was signed on 30 July 2025, with the balance sheet date for the merger set as 1 June 2025 [1]. - Pärnu Riverside Development OÜ will cease to exist post-merger, and Nordic Fibreboard AS will become its legal successor [4]. - No merger report will be prepared, and the merger agreement does not require auditing [5]. Group 2: Share Capital Increase - The Supervisory Board proposes a conditional increase of Nordic Fibreboard AS's share capital by €400,000, bringing the total conditional share capital to €849,906.1 [6]. - The purpose of the capital increase is to facilitate a public offering of shares and list them on the secondary list of the Nasdaq Tallinn Stock Exchange [6]. - The issue price for the new shares is set at €0.50 per share, with €0.10 as nominal value and €0.40 as premium, reflecting the company's financial challenges [6]. Group 3: Shareholder Meeting - An extraordinary general meeting of shareholders is scheduled for 1 September 2025, with registration starting at 9:45 [2]. - The list of shareholders entitled to participate will be fixed as of 25 August 2025 [3]. - Shareholders holding at least 1/20 of the share capital can demand additional agenda items or submit draft resolutions [15][16].